Vesprin

NDA 11325, held by Apothecon. Triflupromazine Hydrochloride.

As of Nov 13, 2026, NDA 11325 (Vesprin), held by Apothecon, was first approved by FDA on Jan 6, 1958, with 0 approved supplements and 0 published complete response letters.

• First approved: Jan 6, 1958
• Review: Standard
• Supplements approved: 0
• Complete response letters: 0

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters